Indeed, our current studies reveal that activation of the AIF death pathway in HeLa MR and U251 glioblastoma cells occurs with increased AIF translocation to the nucleus, evident by nuclear and cytoplasmic fractionation and quantitative immunoblotting, as well as microscopic immunofluorescence (Figure 6A, B). The gene discussed is AIFM1; the disease is glioblastoma.